Beam Therapeutics Inc.BEAMNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank13
Studio
Year-over-Year Change

Cash generated from core business operations

Percentile
P13
Within normal range
vs 3Y Ago
-15.3x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025$-345.10M+0.6%
2024$-347.25M-132.7%
2023$-149.19M-762.3%
2022$22.53M+134.0%
2021$-66.27M+30.8%
2020$-95.74M-33.0%
2019$-72.00M-254.7%
2018$-20.30M-649.8%
2017$-2.71M-